Skip to main content

BRNS

Barinthus Biotherapeutics plc.

Company with tickers: BRNS

CIK
1828185
CUSIP
91864C107
Shares Outstanding
40,848,893
13F Activity (30d)
14 filings 13 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 14
Total Value: $5,290,091
Total Shares: 9,297,185

Institutional Ownership Trend

20 quarters

Holder Concentration

Across 14 13F filers · Δ vs Dec 31, 2025
Top Holder
55.9%
Jun 2023 → Mar 2026 · range 52.4% – 67.6%
−2.3 pts
Top 5
93.2%
Jun 2023 → Mar 2026 · range 93.2% – 98.7%
−4.2 pts
Top 10
99.3%
Jun 2023 → Mar 2026 · range 99.2% – 100.0%
−0.7 pts
HHI
3,596
Jun 2023 → Mar 2026 · range 3,268 – 5,036
Highly concentrated−547

Quarterly Activity

vs Dec 31, 2025
New
6
Increased
1
Decreased
0
Sold Out
1
Unchanged
7
Holder count: +5
Institutional value: +209.8%
Shares held: +281.2%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
No qualifying movers this quarter.

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 14 of 14
Export CSV
Holder Value (USD) % of 13F Shares Open